Big Investors ask Drug Maker Boards not to Denigrate Biosimilars

11-08-2014 WSJ Pharmalot BlogComments (0)


A group of 19 institutional investors is asking the boards of more than two dozen drug makers and biotechs to agree to various business principles in hopes of supporting use of biosimilar medicines.

Read more on WSJ Pharmalot Blog

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top